🎙️So exciting to listen to the latest CardioNerds podcast episode with our #OHSU superstars Pooja Prasad, MD, Khoa Nguyen, and Dr. Abigail Khan✨
podcasts.apple.com/us/podcast/car…

Laith Alkukhun Babak Nazer More winning plays… he hasn’t lost a step! Babak Nazer Laith Alkukhun Katie Lutz, Sanket Gokhale OHSU Cardiology Fellowship

A star guest appearance by Babak Nazer who attended our graduation followed by a 🏀 game the next morning! Chris Chen

A fun reunion with OHSU Cardiology Fellowship alum Paola Roldan, MD The ISHLT #ISHLT2023 Conrad Macon

Enjoyed Grand Rounds by physician-scientist Marmar Vaseghi MD PhD who visited us from UCLA Health. Learned about VT storm, role of the sympathetic nervous system in promoting arrhythmias and neuromodulatory therapies for VT #EPeeps #CardioTwitter Joaquin E. Cigarroa MD FACC MSCAI Saket Sanghai MD FACC FHRS Babak Nazer

Great work by Evan F Shalen, MD and colleagues showing the co-existence and increased prevalence of SUD in ACHD - must read pubmed.ncbi.nlm.nih.gov/36709526/ #achd ACHA Congenital Heart Initiative OHSU Knight Cardio OHSU Department of Surgery OHSU Cardiology Fellowship OHSU News

Learning about echocardiographic assessment of prosthetic aortic and mitral valves with Dr. Arora @BhaskarEchoVA #echofirst #SHD

🔥Hot off press! Check out our published #AJC 📝& presented #ACC23 by Ahmad Al-Abdouh, MD MSMS. Do cerebral embolic protection devices (CEPD)⬇️risk of stroke in #TAVR ❓

✅Meta-analysis of 7 RCTs (3,835 TAVR pts)
✅ #CEPD didn't decrease stroke or💀
🧵Results below⬇️

#CardioTwitter #MedTwitter

Great work by two outstanding trainees! My lesson; just place a temp line rather than trying to avoid one when needing a second Micra in a dependent patient. There may only be one good location that’s already occupied.

Nice write up by OHSU IM Residency Marissa Frazer MD PGY-2 and future EP! Making Peter Jessel and OHSU Cardiology Fellowship proud :).

heartrhythmcasereports.com/article/S2214-…

We presented the results of #PIONEER #HCM #OLE at #ACC23
This is the longest follow up of mavacamten to date - a 5 year study, average follow up at the time of this data cut was 200 weeks.
#CardioTwitter

Congrats to our second year cardiology fellow Ahmed Teebi, MD MPH for his awesome presentation at #ACC23

A great summary slide here
OHSU Cardiology Fellowship